miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects

Wang,Pingyu; Xie,Shuyang; Cui,Aidong; Zhang,Yanxiang; Jiang,Baofa

doi:10.3892/etm.2011.399

miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects

Authors:
- Pingyu Wang
- Shuyang Xie
- Aidong Cui
- Yanxiang Zhang
- Baofa Jiang
View Affiliations

Affiliations: School of Public Health, Shandong University, Jinan, P.R. China, Binzhou Medical University, Yantai, P.R. China, Laiyang Central Hospital of Weifang Medical College, Yantai, P.R. China
Published online on: December 1, 2011 https://doi.org/10.3892/etm.2011.399
Pages: 324-330

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increasing number of studies have shown that the hsa-miR-196a2 rs11614913 polymorphism occurs in different types of cancer, but the results are generally controversial and inadequate, mainly due to limited statistical power. To resolve this issue, the present meta-analysis was carried out. Databases, including PubMed and Embase, were searched using: (miR-196a2[All Fields] OR rs11614913[All Fields]) and (‘neoplasms’[MeSH Terms] OR ‘neoplasms’[All Fields] OR ‘cancer’[All Fields]). Crude odds ratios (ORs) with 95% conﬁdence intervals (CIs) were summarized in forest plots and detailed in tables. A total of 20 studies, including 11,004 cases and 13,693 controls, were included in the meta-analysis. The hsa-miR-196a2 rs11614913 polymorphism was significantly associated with an increased cancer risk in all genetic models (CC vs. TT: OR=1.280, 95% CI 1.131-1.449, P<0.001; CT vs. TT: OR=1.187, 95% CI 1.079-1.306, P<0.001; CC/CT vs. TT: OR=1.216, 95% CI 1.104-1.341, P<0.001; and CC vs. CT/TT: OR=1.115, 95% CI 1.025-1.213, P=0.011). In conclusion, this meta-analysis provides compelling evidence that the hsa-miR-196a2 rs11614913 polymorphism plays a crucial role in the development of cancer. Screening of patients for the hsa-miR-196a2 rs11614913 polymorphism can prove clinically useful for the prediction and prevention of cancer.

View Figures

View References

1.	RC LeeRL FeinbaumV AmbrosThe C. elegans heterochronic gene lin encodes small RNAs with antisense complementarity to linCell758438541993
2.	NC LauLP LimEG WeinsteinDP BartelAn abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegansScience294858862200110.1126/science.106506211679671
3.	LA MacfarlanePR MurphyMicroRNA: biogenesis, function and role in cancerCurr Genomics11537561201010.2174/13892021079317589521532838
4.	DP BartelMicroRNAs: genomics, biogenesis, mechanism, and functionCell116281297200410.1016/S0092-8674(04)00045-514744438
5.	W LiuSY MaoWY ZhuImpact of tiny miRNAs on cancersWorld J Gastroenterol13497502200710.3748/wjg.v13.i4.49717278213
6.	CD DavisSA RossEvidence for dietary regulation of microRNA expression in cancer cellsNutr Rev66477482200810.1111/j.1753-4887.2008.00080.x18667010
7.	LB GaoP BaiXM PanJ JiaLJ LiWB LiangM TangLS ZhangYG WeiL ZhangThe association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysisBreast Cancer Res Treat125571574201110.1007/s10549-010-0993-x20640596
8.	M Lagos-QuintanaR RauhutJ MeyerA BorkhardtT TuschlNew microRNAs from mouse and humanRNA9175179200310.1261/rna.2146903
9.	Z HuJ ChenT TianX ZhouH GuL XuY ZengR MiaoG JinH MaY ChenH ShenGenetic variants of miRNA sequences and non-small cell lung cancer survivalJ Clin Invest11826002608200818521189
10.	H YangCP DinneyY YeY ZhuHB GrossmanX WuEvaluation of genetic variants in microRNA-related genes and risk of bladder cancerCancer Res6825302537200810.1158/0008-5472.CAN-07-599118381463
11.	BC ChristensenM Avissar-WhitingLG OuelletRA ButlerHH NelsonMD McCleanCJ MarsitKT KelseyMature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancerClin Cancer Res1637133720201010.1158/1078-0432.CCR-10-065720501619
12.	Y YeKK WangJ GuH YangJ LinJA AjaniX WuGenetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer riskCancer Prev Res (Phila)1460469200810.1158/1940-6207.CAPR-08-013519138993
13.	Y HorikawaCG WoodH YangH ZhaoY YeJ GuJ LinT HabuchiX WuSingle nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinomaClin Cancer Res1479567962200810.1158/1078-0432.CCR-08-119919047128
14.	GP GeorgeR GangwarRK MandalSN SankhwarRD MittalGenetic variation in microRNA genes and prostate cancer risk in North Indian populationMol Biol Rep3816091615201110.1007/s11033-010-0270-420842445
15.	RD MittalR GangwarGP GeorgeT MittalR KapoorInvestigative role of pre-microRNAs in bladder cancer patients: a case-control study in North IndiaDNA Cell Biol30401406201110.1089/dna.2010.115921345130
16.	Z HuJ LiangZ WangT TianX ZhouJ ChenR MiaoY WangX WangH ShenCommon genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese womenHum Mutat307984200910.1002/humu.2083718634034
17.	AE HoffmanT ZhengC YiD LeadererJ WeidhaasF SlackY ZhangT ParanjapeY ZhuMicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysisCancer Res6959705977200910.1158/0008-5472.CAN-09-023619567675
18.	T TianY ShuJ ChenZ HuL XuG JinJ LiangP LiuX ZhouR MiaoH MaY ChenH ShenA functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in ChineseCancer Epidemiol Biomarkers Prev1811831187200910.1158/1055-9965.EPI-08-081419293314
19.	S PengZ KuangC ShengY ZhangH XuQ ChengAssociation of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese populationDig Dis Sci5522882293201010.1007/s10620-009-1007-x19834808
20.	I CatucciR YangP VerderioS PizzamiglioL HeesenK HemminkiC SutterB WappenschmidtM DickN ArnoldP BugertD NiederacherA MeindlRK SchmutzlerCC BartramF FicarazziL TizzoniD ZaffaroniS ManoukianM BarileMA PierottiP RadiceB BurwinkelP PeterlongoEvaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer casesHum Mutat31E1052E1057201010.1002/humu.2114119847796
21.	T DouQ WuX ChenJ RibasX NiC TangF HuangL ZhouD LuA polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese populationJ Cancer Res Clin Oncol13618531859201010.1007/s00432-010-0844-520229273
22.	MJ KimSS YooYY ChoiJY ParkA functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean populationLung Cancer69127129201010.1016/j.lungcan.2010.04.01520466450
23.	XD LiZG LiXX SongCF LiuA variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosisPathology42669673201010.3109/00313025.2010.52217521080878
24.	Z LiuG LiS WeiJ NiuAK El-NaggarEM SturgisQ WeiGenetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neckCancer11647534760201010.1002/cncr.2532320549817
25.	M OkuboT TaharaT ShibataH YamashitaM NakamuraD YoshiokaJ YonemuraT IshizukaT ArisawaI HirataAssociation between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese PopulationHelicobacter15524531201010.1111/j.1523-5378.2010.00806.x21073609
26.	P QiTH DouL GengFG ZhouX GuH WangCF GaoAssociation of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infectionHum Immunol71621626201010.1016/j.humimm.2010.02.01720188135
27.	K SrivastavaA SrivastavaB MittalCommon genetic variants in premicroRNAs and risk of gallbladder cancer in North Indian populationJ Hum Genet55495499201010.1038/jhg.2010.5420520619
28.	K WangH GuoH HuG XiongX GuanJ LiX XuK YangY BaiA functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese HanBiomarkers15614618201010.3109/1354750X.2010.50529920722507
29.	H ChenLY SunLL ChenHQ ZhengQF ZhangA variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in ChineseIntern Med JJan172011(Epub ahead of print)10.1111/j.1445-59942011.02434.x
30.	YS HongHJ KangJY KwakBL ParkCH YouYM KimH KimAssociation between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean populationJ Prev Med Public Health44125230201110.3961/jpmph.2011.44.3.12521617338
31.	JF ZhanLH ChenZX ChenYW YuanGZ XieAM SunY LiuA functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese populationArch Med Res42144148201110.1016/j.arcmed.2011.04.00121565628
32.	B ZhouK WangY WangM XiZ ZhangY SongL ZhangCommon genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinomaMol Carcinog50499505201110.1002/mc.2074021319225
33.	XW ZhangSD PanYL FengJB LiuJ DongYX ZhangJG ChenZB HuHB ShenRelationship between genetic polymorphism in microRNAs precursor and genetic prediposition of hepatocellular carcinomaZhonghua Yu Fang Yi Xue Za Zhi452392432011(In Chinese).
34.	H AkkızS BayramA BekarE AkgöllüY UlgerA functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control studyJ Viral Hepat18e399e407201121692953
35.	J LittleL BradleyMS BrayM ClyneJ DormanDL EllsworthJ HansonM KhouryJ LauTR O’BrienN RothmanD StroupE TaioliD ThomasH VainioS WacholderC WeinbergReporting, appraising, and integrating data on genotype prevalence and gene-disease associationsAm J Epidemiol156300310200210.1093/oxfordjournals.aje.a00017912181099
36.	JP HigginsSG ThompsonJJ DeeksDG AltmanMeasuring inconsistency in meta-analysesBMJ327557560200310.1136/bmj.327.7414.55712958120
37.	CB BeggM MazumdarOperating characteristics of a rank correlation test for publication biasBiometrics5010881101199410.2307/25334467786990
38.	M EggerSG DaveyM SchneiderC MinderBias in meta-analysis detected by a simple, graphical testBMJ315629634199710.1136/bmj.315.7109.6299310563
39.	BM RyanAI RoblesCC HarrisGenetic variation in microRNA networks: the implications for cancer researchNat Rev Cancer10389402201010.1038/nrc286720495573
40.	R LuthraRR SinghMG LuthraYX LiC HannahAM RomansBA BarkohSS ChenJ EnsorDM MaruRR BroaddusA RashidCT AlbarracinMicroRNA-196a targets annexin A1: a microRNAmediated mechanism of annexin A1 downregulation in cancersOncogene2766676678200810.1038/onc.2008.25618663355
41.	D ShenF NooraieY ElshimaliV LonsberryJ HeS BoseD ChiaD SeligsonHR ChangL GoodglickDecreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysisHum Pathol3715831591200610.1016/j.humpath.2006.06.00116949910
42.	S KimA MisraSNP genotyping: technologies and biomedical applicationsAnnu Rev Biomed Eng9289320200710.1146/annurev.bioeng.9.060906.152037